Gogoro Inc vs Heron Therapeutics Inc — how do they compare? Gogoro Inc trades at $2.51 (market cap $52.19M), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Heron Therapeutics Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| GGR | HRTX | |
|---|---|---|
Market Cap | $52.19M | $61.47M |
Sector | Technology | Health |
52-Week High | $7.50 | $1.49 |
52-Week Low | $2.55 | $0.32 |
Enterprise Value | $354.63M | $168.21M |
Signals from Pluang's Aura AI — not financial advice
GGR trades at $2.63, up 1.94% today, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a net loss of $79.97 million on $281.48 million revenue in 2025, with negative margins and cash flow, though 2026 projections show improvement. Analyst consensus is entirely hold, reflecting caution amid ongoing losses.
Outlook remains challenging with persistent losses and negative cash flow, but low P/S and P/B ratios may attract value investors if operational improvements materialize. Key risks include execution on profitability, competitive pressures, and reliance on future growth initiatives to achieve sustained positive earnings.
Heron Therapeutics (HRTX) trades at $0.3409, up 3.24% today, but faces bearish technical signals with 18 sell indicators versus 6 buys. The company reported Q2 2026 revenue of $37.7 million but missed earnings expectations with a $0.03 per share loss. Despite strong analyst support (94.7% buy ratings), fundamental challenges persist with negative net income margins and elevated EV/EBITDA of 34.03.
Investment outlook remains cautious due to consistent earnings misses and negative cash flow from operations. The primary opportunity lies in analyst optimism and potential product growth, while risks include ongoing profitability challenges and competitive pressures in the biotechnology sector.
Trailing returns across standard periods
Latest headlines on both assets
Gogoro is a global technology leader in battery-swapping ecosystems for electric two-wheelers. It provides smart, sustainable urban mobility solutions and manages an extensive network of battery stations.
Read more on GGR →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →